1. Home
  2. SGLD vs SPRO Comparison

SGLD vs SPRO Comparison

Compare SGLD & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scorpio Gold Corporation American Depositary Shares

SGLD

Scorpio Gold Corporation American Depositary Shares

N/A

Current Price

$3.35

Market Cap

62.0M

Sector

N/A

ML Signal

N/A

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$1.11

Market Cap

67.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGLD
SPRO
Founded
N/A
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.0M
67.0M
IPO Year
2009
2017

Fundamental Metrics

Financial Performance
Metric
SGLD
SPRO
Price
$3.35
$1.11
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
40.8K
★ 472.1K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 111.81
EPS
★ N/A
N/A
Revenue
N/A
★ $66,802,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 39.24
52 Week Low
$3.26
$1.08
52 Week High
$5.45
$3.08

Technical Indicators

Market Signals
Indicator
SGLD
SPRO
Relative Strength Index (RSI) 33.40 42.98
Support Level $3.26 $1.10
Resistance Level $3.82 $1.28
Average True Range (ATR) 0.23 0.06
MACD 0.03 -0.00
Stochastic Oscillator 16.98 10.00

Price Performance

Historical Comparison
SGLD
SPRO

About SGLD Scorpio Gold Corporation American Depositary Shares

Scorpio Gold Corp is a company that is engaged in mineral exploitation, exploration, and development in the United States. It holds an interest in the Mineral Ridge gold project, which is located in the northwest of the town of Silver Peak and west of Tonopah in Esmeralda County, Nevada. Its other project includes the Goldwedge property, which is located north-northeast of the town of Tonopah within the Manhattan Mining District of south-central Nevada.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: